Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
22 June 2018Website:
http://www.electrocore.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 05 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
ECOR Latest News
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has agreed to acquire a 0.85% Gross Revenue Royalty (GRR) over the Phalaborwa rare earth project in South Africa for a total cash consideration of US$8.5 million. In addition, Ecora has subscribed for US$1.5 million in new shares in Rainbow Rare Earths, the project's owner The investment represents Ecora's first rare earth exposure and is in line with a stated strategy of further diversifying and growing its portfolio of future-facing commodity royalties.
Shares in Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) are "cheap", said broker Peel Hunt in a short note following an update on a project over which Ecora has a royalty agreement. Peel picked up on the news from Capstone Copper, which on Tuesday announced the production of the first saleable concentrate from the Mantoverde operation, that would process ore from the Santo Domingo copper-iron-gold deposits "in due course".
The average of price targets set by Wall Street analysts indicates a potential upside of 251.8% in electroCore (ECOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The average price targets from analysts on Wall Street suggest a potential increase of 215.9% in electroCore (ECOR). Although the reliability of this metric is uncertain, the optimistic trend in earnings estimates revisions could lead to a rise in the stock price.
electroCore, Inc., a company specializing in bioelectronic medicine and wellness, will release its financial results for the first quarter of 2024 on May 8, 2024, after the market closes. A conference call and webcast will be held at 4:30 PM EDT on the same day for management to discuss the results and address any inquiries.
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $1.22 per share a year ago.
electroCore, Inc. (NASDAQ:ECOR ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Conference Call Participants Destiny Hance – Ladenburg Thalmann Ramakanth Swayampakula – H.C. Wainwright Nick Sherwood – Maxim Group, LLC Walter Schenker – MAZ Partners Operator Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call.
electroCore, Inc. (NASDAQ:ECOR ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Daniel Goldberger - CEO & Director Brian Posner - CFO & Corporate Secretary Conference Call Participants John Vandermosten - Zacks Swayampakula Ramakanth - H.C. Wainwright & Co. Nick Sherwood - Maxim Tyler Bussian - Brookline Capital Markets Operator Greetings, and welcome to the electroCore Second Quarter 2023 Earnings Conference Call.
electroCore, Inc. (NASDAQ:ECOR ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Nicole Jones - IR Dan Goldberger - Chief Executive Officer Brian Posner - Chief Financial Officer Conference Call Participants John Vandermosten - Zacks Small-Cap Research Ramakanth Swayampakula - H.C. Wainwright Kemp Dolliver - Brookline Capital Markets Nick Sherwood - Maxim Group Operator And welcome to the electroCore First Quarter 2023 Earnings Call.
What type of business is electroCore?
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
What sector is electroCore in?
electroCore is in the Healthcare sector
What industry is electroCore in?
electroCore is in the Medical Devices industry
What country is electroCore from?
electroCore is headquartered in United States
When did electroCore go public?
electroCore initial public offering (IPO) was on 22 June 2018
What is electroCore website?
https://www.electrocore.com
Is electroCore in the S&P 500?
No, electroCore is not included in the S&P 500 index
Is electroCore in the NASDAQ 100?
No, electroCore is not included in the NASDAQ 100 index
Is electroCore in the Dow Jones?
No, electroCore is not included in the Dow Jones index
When does electroCore report earnings?
The next expected earnings date for electroCore is 09 August 2024